Search research articles
Contact Us
Filters
Showing results (21-30 of 111) with videos related to
Page
of 12
Sort By:
Molecular Cancer Therapeutics
|
November 1, 2011
Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies
Robert M Sharkey, Serengulam V Govindan, Thomas M Cardillo, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 2, 2010
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies
Robert M Sharkey, Edmund A Rossi, Chien-Hsing Chang, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 5, 2009
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap
M Jules Mattes, Rosana B Michel, David M Goldenberg, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
September 6, 2011
The radiolabeling of proteins by the [18F]AlF method
William J McBride, Christopher A D'Souza, Robert M Sharkey, et al.
Update on Cancer Therapeutics
|
March 4, 2008
Cancer Imaging and Therapy with Bispecific Antibody Pretargeting
David M Goldenberg, Jean-Francois Chatal, Jacques Barbet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2005
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
David M Goldenberg, Robert M Sharkey, Giovanni Paganelli, et al.
Bioconjugate Chemistry
|
January 26, 2012
New lyophilized kit for rapid radiofluorination of peptides
William J McBride, Christopher A D'Souza, Habibe Karacay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2011
Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys
Thomas M Cardillo, Serengulam V Govindan, Robert M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab)
M Jules Mattes, Robert M Sharkey, Habibe Karacay, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
January 11, 2014
Al(18) F labeling of peptides and proteins
Peter Laverman, William J McBride, Robert M Sharkey, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 111) with videos related to
Sort By:
Page
of 12
Molecular Cancer Therapeutics
|
November 1, 2011
Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies
Robert M Sharkey, Serengulam V Govindan, Thomas M Cardillo, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 2, 2010
Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies
Robert M Sharkey, Edmund A Rossi, Chien-Hsing Chang, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
May 5, 2009
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap
M Jules Mattes, Rosana B Michel, David M Goldenberg, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
September 6, 2011
The radiolabeling of proteins by the [18F]AlF method
William J McBride, Christopher A D'Souza, Robert M Sharkey, et al.
Update on Cancer Therapeutics
|
March 4, 2008
Cancer Imaging and Therapy with Bispecific Antibody Pretargeting
David M Goldenberg, Jean-Francois Chatal, Jacques Barbet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2005
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
David M Goldenberg, Robert M Sharkey, Giovanni Paganelli, et al.
Bioconjugate Chemistry
|
January 26, 2012
New lyophilized kit for rapid radiofluorination of peptides
William J McBride, Christopher A D'Souza, Habibe Karacay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2011
Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys
Thomas M Cardillo, Serengulam V Govindan, Robert M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab)
M Jules Mattes, Robert M Sharkey, Habibe Karacay, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
January 11, 2014
Al(18) F labeling of peptides and proteins
Peter Laverman, William J McBride, Robert M Sharkey, et al.
Page
of 12